Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 9, 2009 - Issue 9
Submit an article Journal homepage
538
Views
96
CrossRef citations to date
0
Altmetric
Review

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

Albert Fournier Internal medicine, Nephrology Department, University Hospital, Amiens, France. [email protected]
,
Roxana Oprisiu-Fournier Geriatrics Department University Hospital, Amiens, France. [email protected]
,
Jean-Marie Serot Geriatrics Department University Hospital, Amiens, France. [email protected]
,
Olivier Godefroy Neurology Department, University Hospital, Amiens, France. [email protected]
,
Jean-Michel Achard Physiology department, University Hospital, Limoges, France. [email protected]
,
Sebastien Faure Physiology Department, University Hospital, Angers, France. [email protected]
,
Hakim Mazouz Nephrology Department, University Hospital, Amiens, France. [email protected]
,
Mohamed Temmar Cardiology Center, Ghardaia, Algeria. [email protected]
,
Adriana Albu Medical Clinic 2, University Hospital, Cluj-Napoca, Romania. [email protected]
,
Régis Bordet Pharmacology department, University Hospital, Lille, France. [email protected]
,
Olivier Hanon Geriatrics Department, Broca University Hospital, Paris, France. [email protected]
,
François Gueyffier Pharmacology department, INSERM – CIC 201, Lyon University Hospital, France. [email protected]
,
Jiguang Wang Vice Director, Shanghai Institute of Hypertension and Director, Center for Epidemiological and Clinical Trials, Riujin Hospital, University School of Medicine, Shanghai, China. [email protected]
,
Sandra Black Neurology Division, Department of Medicine, Sunny Brook Health Sciences Centre, Toronto, Canada. [email protected]
&
Naoyuki Sato Department of clinical gene therapy, Department of geriatric medicine, Graduate School of medicine, Osaka University, Osaka, Japan. [email protected]
 show all
Pages 1413-1431 | Published online: 09 Jan 2014

Citations (96)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Woojung Lee, Shelly L Gray, Douglas Barthold, Paul K Crane, Eric B Larson & Zachary A Marcum. (2019) Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?. Patient Preference and Adherence 13, pages 1809-1815.
Read now
Intza Hernandorena, Emmanuelle Duron, Jean-Sébastien Vidal & Olivier Hanon. (2017) Treatment options and considerations for hypertensive patients to prevent dementia. Expert Opinion on Pharmacotherapy 18:10, pages 989-1000.
Read now
Leonid Feldman, Shlomo Vinker, Shai Efrati, Ilia Beberashvili, Oleg Gorelik, Walter Wasser & Michal Shani. (2016) Amlodipine treatment of hypertension associates with a decreased dementia risk. Clinical and Experimental Hypertension 38:6, pages 545-549.
Read now
Yutaka Mori, Shizuka Aritomi, Kazumi Niinuma, Tarou Nakamura, Kenichi Matsuura, Junichi Yokoyama & Kazunori Utsunomiya. (2014) Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus. Drug Design, Development and Therapy 8, pages 799-810.
Read now
Emma Louise Ashby & Patrick G Kehoe. (2013) Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease. Expert Opinion on Investigational Drugs 22:10, pages 1229-1242.
Read now
Lucy Nelson, Naji Tabet, Cassie Richardson & Paul Gard. (2013) Antihypertensives, angiotensin, glucose and Alzheimer’s disease. Expert Review of Neurotherapeutics 13:5, pages 477-482.
Read now
Elizabeth M. Hudak, Jerri D. Edwards, Ponrathi Athilingam & Cathy L. McEvoy. (2013) A Comparison of Cognitive and Everyday Functional Performance Among Older Adults With and Without Hypertension. Clinical Gerontologist 36:2, pages 113-131.
Read now
Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt & Péter Mátyus. (2012) Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 21:9, pages 1267-1308.
Read now
Ghazi Ahmad Radaideh, Patrick Choueiry, Amr Ismail, Elie Eid, Jean-Pascal Berrou, Armand Sedefdjian, Frank Sévenier & Atul Pathak. (2011) Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study. Vascular Health and Risk Management 7, pages 491-495.
Read now
Chengxuan Qiu. (2011) Epidemiological findings of vascular risk factors in Alzheimer’s disease: implications for therapeutic and preventive intervention. Expert Review of Neurotherapeutics 11:11, pages 1593-1607.
Read now
Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, Florent Boutitie, Jean-Marie Serot, Jean-Michel Achard, Olivier Godefroy, Olivier Hanon, Mohammed Temmar, Adriana Albu, Svend Strandgaard, Jiguang Wang, Sandra E Black & Albert Fournier. (2009) Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?. Expert Review of Neurotherapeutics 9:9, pages 1289-1305.
Read now

Articles from other publishers (85)

Marion Pépin, Aleksandra Klimkowicz‐Mrowiec, Olivier Godefroy, Pilar Delgado, Sol Carriazo, Ana Carina Ferreira, Aleksandra Golenia, Jolanta Malyszko, Tomasz Grodzicki, Konstantinos Giannakou, Giuseppe Paolisso, Michelangela Barbieri, Liliana Garneata, Carmen Antonia Mocanu, Sophie Liabeuf, Goce Spasovski, Carmine Zoccali, Annette Bruchfeld, Ana Farinha, Mustafa Arici, Giovambattista Capasso, Andrzej Wiecek & Ziad A. Massy. (2023) Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment. European Journal of Neurology 30:9, pages 2899-2911.
Crossref
Hyun Kim, Ting Fang Alvin Ang, Robert J. Thomas, Michael J. Lyons & Rhoda Au. (2023) Long‐term blood pressure patterns in midlife and dementia in later life: Findings from the Framingham Heart Study. Alzheimer's & Dementia.
Crossref
Ming Sun, Chao Wu, Lixin Liu, Liang Gu, Zihao Wang, Feng Xu & Donglin Zhu. (2023) Interplay between the renin angiotensin system and oxidative stress contributes to alcohol addiction by stimulating dopamine accumulation in the mesolimbic pathway. Biochemical Pharmacology 212, pages 115578.
Crossref
David A. Loeffler. (2023) Experimental approaches for altering the expression of Abeta‐degrading enzymes. Journal of Neurochemistry 164:6, pages 725-763.
Crossref
Ke Ma, Zi-Run Zheng & Yu Meng. (2023) Pathogenesis of Chronic Kidney Disease Is Closely Bound up with Alzheimer’s Disease, Especially via the Renin-Angiotensin System. Journal of Clinical Medicine 12:4, pages 1459.
Crossref
Mohammed Yusuf Ansari, Vaisali Chandrasekar, Ajay Vikram Singh & Sarada Prasad Dakua. (2023) Re-Routing Drugs to Blood Brain Barrier: A Comprehensive Analysis of Machine Learning Approaches With Fingerprint Amalgamation and Data Balancing. IEEE Access 11, pages 9890-9906.
Crossref
Yun Li, Hong Yang, Tianhan He, Liang Zhang & Chao Liu. (2022) Post-Translational Modification of Cav1.2 and its Role in Neurodegenerative Diseases. Frontiers in Pharmacology 12.
Crossref
Jean K. Ho, Frank Moriarty, Jennifer J. Manly, Eric B. LarsonDenis A. EvansKumar B. RajanElizabeth M. HudakLamiaa Hassan, Enwu Liu, Nobuyuki SatoNaoyuki HasebeDanielle LaurinPierre-Hugues Carmichael & Daniel A. Nation. (2021) Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis. Hypertension 78:3, pages 629-643.
Crossref
Michael Ouk, Che-Yuan Wu, Jennifer S. Rabin, Jodi D. Edwards, Joel Ramirez, Mario Masellis, Richard H. Swartz, Nathan Herrmann, Krista L. Lanctôt, Sandra E. Black & Walter Swardfager. (2021) Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Neurobiology of Aging 100, pages 22-31.
Crossref
Jason D. Vadhan & Robert C. Speth. (2021) The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI). Pharmacology & Therapeutics 218, pages 107684.
Crossref
Nupur Mishra, Devyani Mohan, Sehrish Fuad, Deepak M Basavanagowda, Zaid A Alrashid, Arveen Kaur, Bindu Rathod, Sadia Nosher & Stacey E Heindl. (2020) The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review. Cureus.
Crossref
Sevil Yasar, Kyle D. Moored, Atif Adam, Fiona Zabel, Yi-Fang Chuang, Vijay R. Varma & Michelle C. Carlson. (2020) Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults. Journal of Alzheimer's Disease 75:2, pages 521-529.
Crossref
Abdel G. Elkahloun & Juan M. Saavedra. (2019) Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis. Molecular Neurobiology 57:3, pages 1656-1673.
Crossref
Romain Barus, Johana Béné, Julie Deguil, Sophie Gautier & Régis Bordet. (2019) Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia. British Journal of Pharmacology 176:18, pages 3413-3434.
Crossref
Henning J. Drews, Konstantin Yenkoyan, Ali Lourhmati, Marine Buadze, Daniela Kabisch, Stephan Verleysdonk, Stefan Petschak, Sandra Beer-Hammer, Tigran Davtyan, William H. FreyIIII, Christoph H. Gleiter, Matthias Schwab & Lusine Danielyan. (2019) Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats. Neurotherapeutics 16:3, pages 725-740.
Crossref
Nabidzhon Khamidovich Khamidov, Nazhmidin Mamatovich Khursanov & Anvar Nuralievich Lolaev. (2019) COGNITIVE IMPAIRMENTS IN PATIENTS WITH ARTERIAL HYPERTENSION. AVICENNA BULLETIN 21:2, pages 321-327.
Crossref
B. Petek, M. Villa‐Lopez, R. Loera‐Valencia, G. Gerenu, B. Winblad, M. G. Kramberger, M.‐A.‐M. Ismail, M. Eriksdotter & S. Garcia‐Ptacek. (2018) Connecting the brain cholesterol and renin–angiotensin systems: potential role of statins and RAS ‐modifying medications in dementia . Journal of Internal Medicine 284:6, pages 620-642.
Crossref
O. D. Ostroumova & M. S. Chernyaeva. (2018) Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics. Cardiovascular Therapy and Prevention 17:5, pages 79-91.
Crossref
T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova & E. V. Borisova. (2018) Effect of indapamide/perindopril fixed-dose combination on 24-hour blood pressure and cognitive functions in treatment-naive middle-aged patients with essential arterial hypertension. Neurology, Neuropsychiatry, Psychosomatics 10:3, pages 19-28.
Crossref
Sevil Yasar, Vijay R. Varma, Gregory C. Harris & Michelle C. Carlson. (2018) Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function. Journal of Alzheimer's Disease 63:2, pages 655-664.
Crossref
O. Godefroy, M. Barbay & M. Roussel. (2018) Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge. Pratique Neurologique - FMC 9:2, pages 132-139.
Crossref
Patrick Gavin Kehoe. (2018) The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?. Journal of Alzheimer's Disease 62:3, pages 1443-1466.
Crossref
Ruby Goel, Shahnawaz Ali Bhat, Kashif Hanif, Chandishwar Nath & Rakesh Shukla. (2017) Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats. Molecular Neurobiology 55:2, pages 1725-1739.
Crossref
Jean K. Ho & Daniel A. Nation. (2017) Memory is preserved in older adults taking AT1 receptor blockers. Alzheimer's Research & Therapy 9:1.
Crossref
Jodi D. Edwards, Joel Ramirez, Brandy L. Callahan, Sheldon W. Tobe, Paul Oh, Courtney Berezuk, Krista Lanctôt, Walter Swardfager, Sean Nestor, Alexander Kiss, Stephen Strother & Sandra E. Black. (2017) Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study. Journal of Alzheimer's Disease 59:3, pages 1113-1122.
Crossref
Milton Packer & John J V McMurray. (2017) Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure. The Lancet 389:10081, pages 1831-1840.
Crossref
Nobuharu Fujiwara, Atsushi Tanaka, Atsushi Kawaguchi, Motoko Tago, Jun-ichi Oyama, Yasufumi Uchida, Kazuo Matsunaga, Kazuo Moroe, Shigeru Toyoda, Teruo Inoue, Hideo Ikeda & Koichi Node. (2017) Association Between Blood Pressure Lowering and Quality of Life by Treatment of Azilsartan. International Heart Journal 58:5, pages 752-761.
Crossref
Xianglai Xu, Brian Wang, Changhong Ren, Jiangnan Hu, David A. Greenberg, Tianxiang Chen, Liping Xie & Kunlin Jin. (2017) Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases. Aging and disease 8:4, pages 486.
Crossref
Luis Augusto Juncos, Kiran Chandrashekar & Luis Isaías Juncos. 2017. Psychiatry and Neuroscience Update - Vol. II. Psychiatry and Neuroscience Update - Vol. II 515 539 .
Penny A. Dacks, Joshua J. Armstrong, Stephen K. Brannan, Aaron J. Carman, Allan M. Green, M. Sue Kirkman, Lawrence R. Krakoff, Lewis H. Kuller, Lenore J. Launer, Simon Lovestone, Elizabeth Merikle, Peter J. Neumann, Kenneth Rockwood, Diana W. Shineman, Richard G. Stefanacci, Priscilla Velentgas, Anand Viswanathan, Rachel A. Whitmer, Jeff D. Williamson & Howard M. Fillit. (2016) A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline. Alzheimer's Research & Therapy 8:1.
Crossref
Baris Afsar, Alan A. Sag, Can Ege Yalcin, Eren Kaya, Dimitrie Siriopol, David Goldsmith, Adrian Covic & Mehmet Kanbay. (2016) Brain-kidney cross-talk: Definition and emerging evidence. European Journal of Internal Medicine 36, pages 7-12.
Crossref
Shahnawaz Ali Bhat, Ruby Goel, Rakesh Shukla & Kashif Hanif. (2015) Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition. Molecular Neurobiology 53:10, pages 6950-6967.
Crossref
Shan Zhuang, Hai-Feng Wang, Xin Wang, Jun Li & Cheng-Ming Xing. (2016) The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer’s disease: A meta-analysis. Journal of Clinical Neuroscience 33, pages 32-38.
Crossref
Milton Packer. (2016) Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA. European Journal of Heart Failure 18:10, pages 1211-1219.
Crossref
Sevil Yasar, Mattan Schuchman, Jean Peters, Kaarin J. Anstey, Michelle C. Carlson & Ruth Peters. (2016) Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials. Current Hypertension Reports 18:8.
Crossref
Shan Zhuang, Hai-feng Wang, Jun Li, Hong-yan Wang, Xin Wang & Cheng-ming Xing. (2016) Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis. Neuroscience Letters 624, pages 53-61.
Crossref
Brice Ongali, Nektaria Nicolakakis, Xing-Kang Tong, Tahar Aboulkassim, Hans Imboden & Edith Hamel. (2016) Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 51:4, pages 1183-1195.
Crossref
Walter Swardfager & Sandra E. Black. (2016) Coronary Artery Calcification. Journal of the American College of Cardiology 67:9, pages 1023-1026.
Crossref
Edith Hamel, Jessika Royea, Brice Ongali & Xin-Kang Tong. (2016) Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy. Cellular and Molecular Neurobiology 36:2, pages 219-232.
Crossref
Emma L. Ashby, James S. Miners, Patrick G. Kehoe & Seth Love. (2016) Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex. Journal of Alzheimer's Disease 50:4, pages 1191-1203.
Crossref
Shan Zhuang, Jun Li, Xin Wang, Hai-feng Wang, Wei-jie Zhang, Hong-yan Wang & Cheng-ming Xing. (2016) Renin–angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis. Neuroscience Letters 615, pages 1-8.
Crossref
. 2016. Alzheimer's Disease. Alzheimer's Disease 353 428 .
Nisharahmed Kherada, Todd Heimowitz & Clive Rosendorff. (2015) Antihypertensive Therapies and Cognitive Function: a Review. Current Hypertension Reports 17:10.
Crossref
Lucy Nelson & Naji Tabet. (2015) Slowing the progression of Alzheimer’s disease; what works?. Ageing Research Reviews 23, pages 193-209.
Crossref
Jean Peters, Andrew Booth & Ruth Peters. (2015) Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Therapeutic Advances in Chronic Disease 6:4, pages 160-169.
Crossref
Ruby Goel, Shahnawaz Ali Bhat, N. Rajasekar, Kashif Hanif, Chandishwar Nath & Rakesh Shukla. (2015) Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition. Pharmacology Biochemistry and Behavior 133, pages 132-145.
Crossref
Shizuka Aritomi, Eri Harada, Kazumi Sugino, Mai Nishimura, Tarou Nakamura & Akira Takahara. (2015) Comparison of the cardioprotective and renoprotective effects of the L/N‐type calcium channel blocker, cilnidipine, in adriamycin‐treated spontaneously‐hypertensive rats. Clinical and Experimental Pharmacology and Physiology 42:4, pages 344-352.
Crossref
V N Shishkova. (2015) The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia. Systemic Hypertension 12:1, pages 58-64.
Crossref
Ruth Peters, Andrew Booth & Jean Peters. (2014) A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly. Journal of Hypertension 32:10, pages 1945-1958.
Crossref
Eiichi Katada, Norihiko Uematsu, Yuko Takuma & Noriyuki Matsukawa. (2014) Comparison of Effects of Valsartan and Amlodipine on Cognitive Functions and Auditory P300 Event-Related Potentials in Elderly Hypertensive Patients. Clinical Neuropharmacology 37:5, pages 129-132.
Crossref
Brice Ongali, Nektaria Nicolakakis, Xin-Kang Tong, Tahar Aboulkassim, Panayiota Papadopoulos, Pedro Rosa-Neto, Clotilde Lecrux, Hans Imboden & Edith Hamel. (2014) Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model. Neurobiology of Disease 68, pages 126-136.
Crossref
Dennis A Davey. (2014) Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease? Part II: Management, prevention and future perspective. Neurodegenerative Disease Management 4:3, pages 261-270.
Crossref
Birce Buturak, Serdar Durdagi, Sergei Y. Noskov & A. Tugba Ozal Ildeniz. (2014) Designing of multi-targeted molecules using combination of molecular screening and in silico drug cardiotoxicity prediction approaches. Journal of Molecular Graphics and Modelling 50, pages 16-34.
Crossref
Wei-Che Chiu, Wen-Chao Ho, Meng-Hung Lin, Hsiu-Hao Lee, Yu-Chi Yeh, Jung-Der Wang & Pau-Chung Chen. (2014) Angiotension receptor blockers reduce the risk of dementia. Journal of Hypertension 32:4, pages 938-947.
Crossref
Michiaki Nagai, Satoshi Hoshide, Mami Nishikawa, Shimpo Masahisa & Kazuomi Kario. (2014) Visit-to-visit blood pressure variability in the elderly: Associations with cognitive impairment and carotid artery remodeling. Atherosclerosis 233:1, pages 19-26.
Crossref
Martins Rucins, Dainis Kaldre, Karlis Pajuste, Maria A.S. Fernandes, Joaquim A.F. Vicente, Linda Klimaviciusa, Elina Jaschenko, Iveta Kanepe-Lapsa, Irina Shestakova, Mara Plotniece, Marina Gosteva, Arkadij Sobolev, Baiba Jansone, Ruta Muceniece, Vija Klusa & Aiva Plotniece. (2014) Synthesis and studies of calcium channel blocking and antioxidant activities of novel 4-pyridinium and/or N-propargyl substituted 1,4-dihydropyridine derivatives. Comptes Rendus Chimie 17:1, pages 69-80.
Crossref
George Bartzokis & Po H. Lu. 2014. White Matter Injury in Stroke and CNS Disease. White Matter Injury in Stroke and CNS Disease 281 319 .
Rónán O’CaoimhPatrick Gavin Kehoe, Paul Kennedy & William Molloy. (2013) Use of angiotensin-converting enzyme inhibitors for Alzheimer’s disease: an update. Neurodegenerative Disease Management 3:6, pages 511-514.
Crossref
M. Nagai & K. Kario. (2013) Visit-to-Visit Blood Pressure Variability, Silent Cerebral Injury, and Risk of Stroke. American Journal of Hypertension 26:12, pages 1369-1376.
Crossref
Ewa Szczepanska‐Sadowska. 2013. Metabolic Syndrome and Neurological Disorders. Metabolic Syndrome and Neurological Disorders 439 459 .
Sevil YasarJin XiaWenliang YaoCurt D. FurbergQian-Li XueCarla I. MercadoAnnette L. FitzpatrickLinda P. FriedClaudia H. KawasKaycee M. SinkJeff D. WilliamsonSteven T. DeKoskyMichelle C. Carlson. (2013) Antihypertensive drugs decrease risk of Alzheimer disease. Neurology 81:10, pages 896-903.
Crossref
Natacha Levi Marpillat, Isabelle Macquin-Mavier, Anne-Isabelle Tropeano, Anne-Catherine Bachoud-Levi & Patrick Maison. (2013) Antihypertensive classes, cognitive decline and incidence of dementia. Journal of Hypertension 31:6, pages 1073-1082.
Crossref
. (2013) Current World Literature. Current Opinion in Psychiatry 26:3, pages 295-303.
Crossref
Vincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi, Davide Seripa, Giancarlo Logroscino, Patrick G. Kehoe, Bruno P. Imbimbo, Marzia Baldereschi, Gaetano Crepaldi, Antonio Di Carlo, Lucia Galluzzo, Claudia Gandin, Domenico Inzitari, Stefania Maggi, Alberto Pilotto & Francesco Panza. (2011) Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. AGE 35:2, pages 441-453.
Crossref
Jean-Marc Bugnicourt, Olivier Godefroy, Jean-Marc Chillon, Gabriel Choukroun & Ziad A. Massy. (2013) Cognitive Disorders and Dementia in CKD. Journal of the American Society of Nephrology 24:3, pages 353-363.
Crossref
John W. Wright & Joseph W. Harding. (2012) The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases. Pflügers Archiv - European Journal of Physiology 465:1, pages 133-151.
Crossref
Jan Józef Braszko, Dominik Wincewicz & Piotr Jakubów. (2012) Candesartan prevents impairment of recall caused by repeated stress in rats. Psychopharmacology 225:2, pages 421-428.
Crossref
Bruno Vellas & Phillipe RobertS. Sourdet. 2013. Traité sur la maladie d’Alzheimer. Traité sur la maladie d’Alzheimer 421 436 .
Juan M. Saavedra. (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clinical Science 123:10, pages 567-590.
Crossref
Kie Honjo, Sandra E. Black & Nicolaas P. L. G. Verhoeff. (2014) Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 39:6, pages 712-728.
Crossref
Sara ContiPaola CassisAriela Benigni. (2012) Aging and the Renin-Angiotensin System. Hypertension 60:4, pages 878-883.
Crossref
Philip B. Gorelick & David Nyenhuis. (2012) Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function. Journal of the American Society of Hypertension 6:5, pages 309-315.
Crossref
Michiaki Nagai, Satoshi Hoshide, Joji Ishikawa, Kazuyuki Shimada & Kazuomi Kario. (2012) Visit-to-visit blood pressure variations. Journal of Hypertension 30:8, pages 1556-1563.
Crossref
Majon Muller, Yolanda van der Graaf, Frank L. Visseren, Willem P. Th. M. Mali & Mirjam I. Geerlings. (2012) Hypertension and longitudinal changes in cerebral blood flow: The SMART‐MR study. Annals of Neurology 71:6, pages 825-833.
Crossref
Robert J. PetrellaEvgeny ShlyakhtoAlexandra O. KonradiJean‐Pascal BerrouArmand SedefdjianAtul Pathak. (2012) Blood Pressure Responses to Hypertension Treatment and Trends in Cognitive Function in Patients With Initially Difficult‐to‐Treat Hypertension: A Retrospective Subgroup Analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) Study. The Journal of Clinical Hypertension 14:2, pages 78-84.
Crossref
Mark F. McCarty. (2012) Marinobufagenin and cyclic strain may activate endothelial NADPH oxidase, contributing to the adverse impact of salty diets on vascular and cerebral health. Medical Hypotheses 78:2, pages 191-196.
Crossref
J. Campion, K. Bhui & D. Bhugra. (2020) European Psychiatric Association (EPA) guidance on prevention of mental disorders. European Psychiatry 27:2, pages 68-80.
Crossref
John W. Wright & Joseph W. Harding. (2011) Brain renin-angiotensin—A new look at an old system. Progress in Neurobiology 95:1, pages 49-67.
Crossref
Reyna L. VanGilder, Charles L. Rosen, Taura L. Barr & Jason D. Huber. (2011) Targeting the neurovascular unit for treatment of neurological disorders. Pharmacology & Therapeutics 130:3, pages 239-247.
Crossref
Daniel Paris, Corbin Bachmeier, Nikunj Patel, Amita Quadros, Claude-Henry Volmar, Vincent Laporte, Jim Ganey, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, Fiona Crawford & Michael J. Mullan. (2010) Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier. Molecular Medicine 17:3-4, pages 149-162.
Crossref
Vikas Dhikav & Kuljeet Anand. (2011) Potential Predictors of Hippocampal Atrophy in Alzheimerʼs Disease. Drugs & Aging 28:1, pages 1-11.
Crossref
Juan M. Saavedra, Enrique Sánchez-Lemus & Julius Benicky. (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36:1, pages 1-18.
Crossref
Paul R Gard. (2010) Non-adherence to antihypertensive medication and impaired cognition: which comes first?. International Journal of Pharmacy Practice 18:5, pages 252-259.
Crossref
Lusine DanielyanRoman KleinLeah R. HansonMarine BuadzeMatthias SchwabChristoph H. GleiterWilliam H. FreyIIII. (2010) Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease. Rejuvenation Research 13:2-3, pages 195-201.
Crossref
Peter M Rothwell. (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. The Lancet 375:9718, pages 938-948.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.